GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (NAS:ONVO) » Definitions » Cyclically Adjusted PB Ratio

Organovo Holdings (Organovo Holdings) Cyclically Adjusted PB Ratio : 0.11 (As of Jun. 11, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Organovo Holdings Cyclically Adjusted PB Ratio?

As of today (2024-06-11), Organovo Holdings's current share price is $0.9695. Organovo Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $9.02. Organovo Holdings's Cyclically Adjusted PB Ratio for today is 0.11.

The historical rank and industry rank for Organovo Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

ONVO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.1   Med: 0.35   Max: 3.07
Current: 0.11

During the past years, Organovo Holdings's highest Cyclically Adjusted PB Ratio was 3.07. The lowest was 0.10. And the median was 0.35.

ONVO's Cyclically Adjusted PB Ratio is ranked better than
86.08% of 661 companies
in the Biotechnology industry
Industry Median: 1.67 vs ONVO: 0.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Organovo Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $0.357. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Organovo Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Organovo Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings Cyclically Adjusted PB Ratio Chart

Organovo Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 1.49 0.47 0.22 0.11

Organovo Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.17 0.13 0.12 0.11

Competitive Comparison of Organovo Holdings's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Organovo Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organovo Holdings's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Organovo Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Organovo Holdings's Cyclically Adjusted PB Ratio falls into.



Organovo Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Organovo Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.9695/9.02
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organovo Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Organovo Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.357/131.7762*131.7762
=0.357

Current CPI (Mar. 2024) = 131.7762.

Organovo Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.195 100.560 14.670
201409 13.290 100.428 17.438
201412 12.009 99.070 15.974
201503 11.945 99.621 15.801
201506 18.462 100.684 24.163
201509 16.496 100.392 21.653
201512 14.941 99.792 19.730
201603 13.460 100.470 17.654
201606 11.872 101.688 15.385
201609 11.197 101.861 14.485
201612 13.623 101.863 17.624
201703 11.929 102.862 15.282
201706 10.834 103.349 13.814
201709 9.739 104.136 12.324
201712 8.891 104.011 11.264
201803 8.031 105.290 10.051
201806 7.299 106.317 9.047
201809 6.748 106.507 8.349
201812 6.058 105.998 7.531
201903 5.854 107.251 7.193
201906 5.548 108.070 6.765
201909 4.765 108.329 5.796
201912 4.437 108.420 5.393
202003 4.080 108.902 4.937
202006 3.795 108.767 4.598
202009 2.969 109.815 3.563
202012 2.916 109.897 3.497
202103 4.521 111.754 5.331
202106 4.292 114.631 4.934
202109 3.945 115.734 4.492
202112 3.595 117.630 4.027
202203 3.468 121.301 3.767
202206 3.174 125.017 3.346
202209 2.870 125.227 3.020
202212 2.558 125.222 2.692
202303 1.759 127.348 1.820
202306 1.351 128.729 1.383
202309 0.970 129.860 0.984
202312 0.628 129.419 0.639
202403 0.357 131.776 0.357

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Organovo Holdings  (NAS:ONVO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Organovo Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Organovo Holdings (Organovo Holdings) Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Executives
David Gobel director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Vaidehi Joshi director C/O ORGANOVO HOLDINGS, INC., 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO CA 92121
Alison Tjosvold Milhous director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Adam K Stern director STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Thomas Hess officer: President, CFO and PFO 366 MADISON AVE. 12TH FLOOR, NEW YORK NY 10017
Douglas Jay Cohen director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Thomas E Jurgensen officer: General Counsel & Secretary 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Jeffrey N. Miner officer: Chief Scientific Officer 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Chris Heberlig officer: President and CFO C/O KINIKSA PHARMACEUTICALS, LTD., CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON D0 HM11
Keith Murphy director, officer: Executive Chairman 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Steven George Hughes officer: Chief Medical Officer 6275 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Carolyn Beaver director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
David Shapiro director C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES ST., NEW YORK NY 10013
Presnell Sharon Collins officer: EVP, Research & Development 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Taylor Crouch director, officer: CEO & President 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075